Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.

@article{Pal2009ExVA,
  title={Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.},
  author={Rakhi Pal and Neelam Krishnan Venkataramana and Abhilash Bansal and Sudheer Balaraju and Majahar Jan and Ravi Chandra and Ashish Dixit and Amit Rauthan and Uday A Murgod and Satish M. Totey},
  journal={Cytotherapy},
  year={2009},
  volume={11 7},
  pages={897-911}
}
BACKGROUND AIMS Spinal cord injury (SCI) is a medically untreatable condition for which stem cells have created hope in the last few years. Earlier pre-clinical reports have shown that transplantation of bone marrow (BM) mesenchymal stromal cells (MSC) in SCI-simulated models can produce encouraging results. In a clinical pilot study, we investigated the… CONTINUE READING